Mischa Hautvast
Project coordinator
- Name
- M. Hautvast
- Telephone
- 071 5276985
- m.hautvast@liacs.leidenuniv.nl
- ORCID iD
- null
Mischa Hautvast is coordinator of the interdisciplinary research programme SAILS and works at LIACS.
Project coordinator
- Faculty of Science
- LIACS
- LIACS Operations - HR & secretariat
- Bularga A., Taggart C., Mendusic F., Kimenai D.M., Wereski R., Lowry M.T. H., Lee Kuan K, Ferry A.V., Stewart S.S., McAllister D.A., Shah Anoop S. V. Anand A., Newby D. E., Mills N.L. & Chapman A. R. (2022), Assessment of Oxygen Supply-Demand Imbalance and Outcomes Among Patients With Type 2 Myocardial Infarction: A Secondary Analysis of the High-STEACS Cluster Randomized Clinical Trial, Jama Network Open 5: e2220162.
- Doudesis D., Ken Lee K., Yang J., Wereski R., Shah A.S.V.., Tsanas A., Anand A., Pickering J.W., Than M.P., Mills N.L. & High-STEACS Investigators (2022), Validation of the myocardial-ischaemic-injury-index machine learning algorithm to guide the diagnosis of myocardial infarction in a heterogenous population: a prespecified exploratory analysis, The Lancet. Digital Health 4(May 2022): .
- Gallacher P.J., Miller-Hodges E., Shah A.S.V., Anand A., Dhaun N., Mills N.L. & High-STEACS Investigators (2021), Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment: A Randomized Clinical Trial, JAMA Internal Medicine 181(9): 1237-1239.
- Chapman A. R., Adamson P.D., Shah Anoop S.V., Anand A., Strachan F.E. & Duncan C. (2020), High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction, JAMA Internal Medicine 141: 161-171.
- Lee Kuan K. Ferry A. V., Anand A., Strachan F. E., Chapman A.R., Mills N.L., Hautvast M., Newby D.E. & Moss D. C. (2019), Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome, Journal of the American College of Cardiology 74: 2032-2043.
- Shah Anoop S V Anand A., Strachan F.E., Ferry A. V., Lee Kuan K., Chapman A. R., Sandeman D., Stables C. L., Adamson P.D., Andrews J. P. M., Anwar M.S., Hung J., Moss A.J., O'Brien R., Berry C., Findlay I., Walker S., Cruickshank A., Reid A., Gray A., Collinson, P. O., Apple F.S., McAllister D.A., Maguire. D., Fox K.A .A., Newby D.E., Tuck C., Harkess R., Parker R.A. Keerie C., Weir C.J. ,J Mills N.L., Marshall L., Stewart S.D. Fujisawa T., Vallejos C.A., Tsanas A., Hautvast M., McPherson J., McKinlay L., Malo J., Fischbacher C.M., Croal. B.L., Leslie S.J., Walker A., Wackett T., Armstrong R., Stirling L., MacDonald C. , Sadat I., Finlay F. , Charles H., Linksted P., Young S., Alexander B. & Duncan C. (2018), High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial, The Lancet 392: 919-928.
- Lindley R.I., Wardlaw J.M., Whiteley W.N., Geoff Cohen G., Blackwell L., Murray G.D., Sandercock P.A.G., 2 & IST-3 Collaborative Group (2015), Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial, Stroke : .
- Sandercock P., Wardlaw J.M., Lindley R.I., Dennis M., Cohen G., Murray G, Innes K., Venables G., Czlonkowska A., Kobayashi A., Ricci S., Murray V., Berge E., Bruins Slot K., Hankey G.J., Correia M., Peeters A., Matz K., Lyrer P., Gubitz G., Phillips S.J. & Arauz A (2012), The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial, The Lancet 379: 2352-2363.